High dose D-serine in the treatment of schizophrenia.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/20541910
Conclusion of this study
These findings support double-blind investigation of D-serine at doses> or =60 mg/kg/d, and suggest effectiveness in treatment of both persistent symptoms and neurocognitive dysfunction.
Supplements analyzed in this study
|
Health conditions analyzed in this study
|
||
|
Functions related to this study
|
||
|
Body systems related to this study
 Nervous System |
